Clinical Trials Browser

Phase 2 × Terminated × tocilizumab × Clear all

NCT04377659 2025-05-28

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Phase 2 Terminated

9 enrolled 8 charts

COVID-19, Respiratory Tract Infections

NCT04370834 2025-02-04

Tocilizumab for Patients With Cancer and COVID-19 Disease

Phase 2 Terminated

1 enrolled 10 charts

Other hematologic neoplasm

Pneumonia, Respiratory Distress Syndrome, Hematologic Neoplasms

NCT04258150 2022-03-31

TRIPPLE-R

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms